A comparison of the inhibitory effects of budesonide, beclomethasone dipropionate, dexamethasone, hydrocortisone and tixocortol pivalate on cytokine release from leukocytes recovered from human bronchoalveolar lavage

Inflammation Research

Volumn 48, Issue 4, 1999, Pages 224-228

  Whelan, C J ^a   Payne, A N ^b   Planquois, J M ^b  

^a UNIVERSITY OF HERTFORDSHIRE   (United Kingdom)

^b Institut de Recherche Jouveinal   (France)

Author keywords

BAL leukocytes; Glucocorticoid; Interferon ; Interleukin 5; Tixocortol pivalate

Indexed keywords

BECLOMETASONE DIPROPIONATE; BUDESONIDE; DEXAMETHASONE; GAMMA INTERFERON; HYDROCORTISONE; INTERLEUKIN 5; TIXOCORTOL PIVALATE;

ARTICLE; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; LEUKOCYTE; LUNG LAVAGE;

ANTI-INFLAMMATORY AGENTS; BECLOMETHASONE; BRONCHOALVEOLAR LAVAGE; BUDESONIDE; CELLS, CULTURED; CYTOKINES; DEXAMETHASONE; DRUG INTERACTIONS; GLUCOCORTICOIDS; HUMANS; HYDROCORTISONE; LEUKOCYTES; PHYTOHEMAGGLUTININS; TETRADECANOYLPHORBOL ACETATE;

EID: 0032930069     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000110050450     Document Type: Article

References (24)

1. [1] Mygind N, Dahl R. The rationale for use of topical corticosteroids in allergic rhinitis. Clin Exp Allergy 1996; 26 Suppl 3: 2-10.
2. [2] Lipworth BJ. Clinical pharmacology of corticosteroids in bronchial asthma. Pharmacol Ther 1993; 58: 173-209.
3. [3] Mygind N, Lund V. Topical corticosteroid therapy of rhinitis. Clin Immunother 1996; 5: 122-36.
4. [4] Djukanovic R, Wilson SJ, Howarth PH. Pathology of rhinitis and bronchial asthma. Clin Exp Allergy 1996; 26 Suppl 3: 44-51.
5. [5] Collins PD, Marleau S, Griffiths-Johnson DA, Jose PJ, Williams TJ. Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo. J Exp Med 1995; 182: 1169-74.
6. [6] Moser R, Fehr J, Bruijnzeel LB. IL-4 controls the selective endothelium-driven transmigration of eosinophils from allergic individuals. J Immunol 1992; 149: 1432-8.
7. [7] Jahnsen FL, Haraldsen G, Aanesen JP, Haye R, Brandtzaeg P. Eosinophil infiltration is related to increased expression of vascular cell adhesion molecule-1 in nasal polyps. Am J Respir Cell Mol Biol 1995; 12: 624-32.
8. [8] Weller PF. Intercellular interactions in the recruitment and functions of human eosinophils. Int Arch Allergy Immunol 1992; 99: 178-83.
9. [9] Jose PJ, Griffiths-Johnson DA, Collins PD, Walsh DT, Moqbel R, Totty NF, et al. Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea-pig model of allergic airways inflammation. J Exp Med 1994; 179: 881-7.
10. [10] Ricci M. T cells cytokines, IgE and allergic inflammation. Int Arch Allergy Immunol 1992; 99: 165-71.
11. [11] Lozewicz S, Wang J, Duddle J, Thomas K, Chalstrey S, Reilly G, et al. Topical glucocorticoids inhibit activation by allergen in the upper respiratory tract. J Allergy Clin Immunol 1992; 89:951-7.
12. [12] Masuyama K, Jacobson MR, Rak S, Meng Q, Sudderick RM, Kay AB, et al. Topical glucocorticoid (fluticasone propionate) inhibits cells expressing mRNA for interleukin-4 in the nasal mucosa in allergen-induced rhinitis. Immunology 1994; 82: 192-9.
13. [13] Wilson JW, Djukanovic R, Howarth PH, Holgate ST. Inhaled beclomethasone dipropionate downregulates airway lymphocyte activation in atopic asthma. Am JRespir Crit Care Med 1994; 149: 86-90.
14. [14] Whelan CJ, Hughes SC, Wren GPA. Inhibition of some aspects of acute inflammation of guinea-pig lung by intraperitoneal dexamethasone and mifepristone: Demonstration of agonist activity of mifepristone in the guinea-pig. Inflamm Res 1995; 44: 131-8.
15. [15] Davies JE, Kellet DN, Staniforth MW, Torossian R, Grouhel A. Pharmacological study of a new anti-inflammatory steroid, Tixocortol pivalate (JO 1016). Arzneim Forsch 1981; 31: 453-9.
16. [16] Crocker IC, Townley RG, Khan MM. Phosphodiesterase inhibitors suppress proliferation of peripheral blood mononuclear cells and interleukin-4 and -5 secretion by human T-helper type 2 cells. Immunopharmacology 1996; 31: 223-5.
17. 2 cells: functional properties, mechanism of regulation and role in disease Lab Invest 1994; 70: 229-306.
18. [18] Levine SJ, Larivee P, Logun C, Angus CW, Shelhamer JA. Corticosteroids differentially regulate secretion of IL-6, IL-8 and G-CSF by a human bronchial epithelial cell line. Am J Physiol 1993; 265: L360-8.
19. [19] Kenakin TP. The relative contribution of affinity and efficacy to agonist activity: organ selectivity of noradrenaline and oxymetazoline with reference to the classification of drug receptors. Br J Pharmacol 1984; 81: 131-42.
20. [20] Simons Jr SS, Oshima H, Szapary D. Higher levels of control: modulation of steroid hormone-regulated gene transcription. Mol Endocrinol 1992; 6: 995-1002.
21. [21] Havel PJ, Busch BL, Curry DL, Johnson PF, Dallman MF, Stern JS. Predominantly glucocorticoid agonist actions of RU-486 in young specific pathogen free Zucker rats. Am J Physiol 1996; 271: R710-7.
22. [22] Gumowski P, de Gournay C, Girard JP. Tixocortol pivalate and beclomethasone dipropionate in seasonal allergic rhinitis: a double-blind study. J Int Med Res 1985; 13: 328-31.
23. [23] McDonald-Gibson WJ, Cuthbert NJ, Poll CT, Gardiner PJ. Dexamethasone and cyclosporin A inhibit cytokine release from human T-lymphocytes. Br J Pharmacol 1995; 116: 4P.
24. [24] Krouwels FH, van der Heijden JF, Lutter R, van Neerven RJJ, Jansen HG, Out TA. Glucocorticosteroids affect functions of airway-derived and blood derived human T cell clones favoring the Th1 profile through 2 mechanisms. Am J Respir Cell Mol Biol 1996; 14: 388-97.